Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2010 Sep;12(9):714-20.
doi: 10.1111/j.1751-7176.2010.00307.x.

Aspirin resistance in hypertensive patients

Beste Ozben  1 , Azra M Tanrikulu, Tomris Ozben, Oguz Caymaz
Affiliations
Randomized Controlled Trial

Aspirin resistance in hypertensive patients

Beste Ozben et al. J Clin Hypertens (Greenwich). 2010 Sep.

Abstract

Aspirin resistance is associated with poor clinical prognosis. The authors investigated aspirin resistance in 200 hypertensive patients (111 men, age: 68.3±11.4 years) by the Ultegra Rapid Platelet Function Assay-ASA (Accumetrics Inc., San Diego, CA). Aspirin resistance was defined as an aspirin reaction unit ≥550. Aspirin resistance was detected in 42 patients. Aspirin resistance was present in 25.6% of the patients with poor blood pressure control, while in 17.8% of the patients with controlled blood pressure (P=.182). Female gender and creatinine levels were significantly higher (P=.028 and P=.030, respectively), while platelet count was significantly lower (P=.007) in aspirin-resistant patients. Multivariate analysis revealed that female gender (odds ratio [OR], 2.445; P=.045), creatinine levels (OR, 1.297; P=.015) and platelet count (OR, 0.993; P=.005) were independent predictors of aspirin resistance. The frequency of aspirin resistance is not low in hypertensive patients. Female hypertensive patients, especially, with higher creatinine levels and lower platelet count are at higher risk for aspirin resistance.

PubMed Disclaimer

References

    1. Ridker PM, Manson JE, Buring JE, et al. The effect of chronic platelet inhibition with low‐dose aspirin on atherosclerotic progression and acute thrombosis: clinical evidence from the Physicians’ Health Study. Am Heart J. 1991;122:1588–1592. - PubMed
    1. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS‐2. ISIS‐2 (Second International Study of Infarct Survival) Collaborative Group. Lancet. 1988;2:349–360. - PubMed
    1. Antithrombotic Trialists’ Collaboration . Collaborative meta‐analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ. 2002;324:71–86. - PMC - PubMed
    1. Hennekens CH, Schror K, Weisman S, et al. Terms and conditions: semantic complexity and aspirin resistance. Circulation. 2004;110:1706–1708. - PubMed
    1. Macchi L, Sorel N, Christiaens L. Aspirin resistance: definitions, mechanisms, prevalence, and clinical significance. Curr Pharm Des. 2006;12:251–258. - PubMed

Publication types